Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 63
Data di pubblicazione Titolo Autore(i) Tipo File
3-mar-2021 Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation Buccisano, F; Palmieri, R; Piciocchi, A; Maurillo, L; Del Principe, Mi; Paterno, G; Soddu, S; Cerretti, R; De Angelis, G; Mariotti, B; Irno Consalvo, Ma; Conti, C; Fraboni, D; Divona, M; Ottone, T; Lavorgna, S; Panetta, P; Voso, Mt; Arcese, W; Venditti, A Articolo su rivista
1-giu-2021 Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C Giansanti, M; De Gabrieli, A; Prete, Sp; Ottone, T; Divona, Md; Karimi, T; Ciccarone, F; Voso, Mt; Graziani, G; Faraoni, I Articolo su rivista
22-set-2021 Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis Fantini, S; Rontauroli, S; Sartini, S; Mirabile, M; Bianchi, E; Badii, F; Maccaferri, M; Guglielmelli, P; Ottone, T; Palmieri, R; Genovese, E; Carretta, C; Parenti, S; Mallia, S; Tavernari, L; Salvadori, C; Gesullo, F; Maccari, C; Zizza, M; Grande, A; Salmoiraghi, S; Mora, B; Potenza, L; Rosti, V; Passamonti, F; Rambaldi, A; Voso, Mt; Mecucci, C; Tagliafico, E; Luppi, M; Vannucchi, Am; Manfredini, R Articolo su rivista
28-set-2021 The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells Almeida, Lyd; Pereira-Martins, Da; Weinhauser, I; Ortiz, C; Candido, La; Lange, Ap; De Abreu, Nf; Mendonza, Ses; de Deus Wagatsuma, Vm; Do Nascimento, Mc; Paiva, Hh; Alves-Paiva, Rm; Bonaldo, Ccom; Nascimento, Dc; Alves-Filho, Jc; Scheucher, Ps; Lima, Asg; Schuringa, Jj; Ammantuna, E; Ottone, T; Noguera, Ni; Araujo, Cl; Rego, Em Articolo su rivista
1-gen-2022 The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19 Cristiano, A; Palmieri, R; Fabiani, E; Ottone, T; Divona, M; Savi, A; Buccisano, F; Maurillo, L; Tarella, C; Arcese, W; Voso, Mt Articolo su rivista
1-gen-2022 CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML Travaglini, S; Ottone, T; Angelini, Df; Fiori, V; Dominici, S; Noguera, Ni; Sniegocka, M; Antonelli, S; Irno Consalvo, Ma; De Bardi, M; Banella, C; Divona, M; Marchesi, F; Masciarelli, S; Fazi, F; Pieraccioli, M; Palmieri, R; De Angelis, G; Buccisano, F; Venditti, A; Battistini, L; Magnani, M; Voso, Mt Articolo su rivista
1-gen-2022 ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A Articolo su rivista
1-gen-2022 Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis Guarnera, L; Ottone, T; Fabiani, E; Divona, M; Savi, A; Travaglini, S; Falconi, G; Panetta, P; Rapanotti, Mc; Voso, Mt Articolo su rivista
1-gen-2022 Vitamin C Deficiency in Patients With Acute Myeloid Leukemia Ottone, T; Faraoni, I; Fucci, G; Divona, M; Travaglini, S; De Bellis, E; Marchesi, F; Angelini, Df; Palmieri, R; Gurnari, C; Giansanti, M; Nardozza, Am; Montesano, F; Fabiani, E; Lindfors Rossi, El; Cerretti, R; Cicconi, L; De Bardi, M; Catanoso, Ml; Battistini, L; Massoud, R; Venditti, A; Voso, Mt Articolo su rivista
1-gen-2022 An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone Borsellino, B; Savi, A; Pascale, M; Meddi, E; Del Principe, M; Cristiano, A; Ottone, T; Rapanotti, M; Divona, M; Travaglini, S; Attardi, E; Palmieri, R; Buzzatti, E; Buccisano, F; Voso, M Articolo su rivista
5-gen-2022 The response to oxidative damage correlates with driver mutations and clinical outcome in patients with myelofibrosis Genovese, E; Mirabile, M; Rontauroli, S; Sartini, S; Fantini, S; Tavernari, L; Maccaferri, M; Guglielmelli, P; Bianchi, E; Parenti, S; Carretta, C; Mallia, S; Castellano, S; Colasante, C; Balliu, M; Bartalucci, N; Palmieri, R; Ottone, T; Mora, B; Potenza, L; Passamonti, F; Voso, Mt; Luppi, M; Vannucchi, Am; Tagliafico, E; Manfredini, R; On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc, N Articolo su rivista
17-mar-2022 Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Maurillo, L; Del Principe, M; Paterno, G; Irno-Consalvo, M; Ottone, T; Divona, M; Conti, C; Fraboni, D; Lavorgna, S; Arcese, W; Voso, Mt; Venditti, A Articolo su rivista
23-mag-2022 Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment Banella, C; Catalano, G; Travaglini, S; Pelosi, E; Ottone, T; Zaza, A; Guerrera, G; Angelini, Df; Niscola, P; Divona, M; Battistini, L; Screnci, M; Ammatuna, E; Testa, U; Nervi, C; Voso, Mt; Noguera, Ni Articolo su rivista
18-giu-2022 Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol Messina, M; Piciocchi, A; Ottone, T; Paolini, S; Papayannidis, C; Lessi, F; Fracchiolla, Ns; Forghieri, F; Candoni, A; Mengarelli, A; Martelli, Mp; Venditti, A; Carella, Am; Albano, F; Mancini, V; Massimo, B; Arena, V; Sargentini, V; Sciumè, M; Pastore, D; Todisco, E; Roti, G; Siragusa, S; Ladetto, M; Pravato, S; De Bellis, E; Simonetti, G; Marconi, G; Cerchione, C; Fazi, P; Vignetti, M; Amadori, S; Martinelli, G; Voso, Mt Articolo su rivista
22-lug-2022 The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia Travaglini, S; Gurnari, C; Antonelli, S; Silvestrini, G; Noguera, Ni; Ottone, T; Voso, Mt Articolo su rivista
20-ott-2022 Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia Pereira-Martins, Da; Coelho-Silva, Jl; Weinhäuser, I; Franca-Neto, Pl; Silveira, Dr; Ortiz, C; Moreira-Aguiar, A; Lima, Mm; Koury, Lc; de Melo, Ra; Glória, Ab; Fagundes, Em; Lino, Bk; Pagnano, K; Bittencourt, R; Nunes, E; Traina, F; Figueiredo-Pontes, L; Keating, A; Tallman, Ms; Ribeiro, Rc; Dilon, R; Ganser, A; Sanz, Ma; Berliner, N; Valk, P; Löwenberg, B; Ottone, T; Noguera, Ni; Voso, Mt; Paoloni, F; Fazi, P; Ammatuna, E; Huls, G; Schuringa, Jj; Rego, Em; Lucena-Araujo, Ar Articolo su rivista
1-gen-2023 Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection Liccardo, F; Sniegocka, M; Tito, C; Iaiza, A; Ottone, T; Divona, M; Travaglini, S; Mattei, M; Cicconi, R; Miglietta, S; Familiari, G; Nottola, Sa; Petrozza, V; Tamagnone, L; Voso, Mt; Masciarelli, S; Fazi, F Articolo su rivista
1-gen-2023 YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells Noguera, N; Travaglini, S; Scalea, S; Catalanotto, C; Reale, A; Zampieri, M; Zaza, A; Rosaria RICCIARDI, M; Angelini, Df; Tafuri, A; Ottone, T; Voso, Mt; Zardo, G Articolo su rivista
1-gen-2023 Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation Nardozza, Am; Guarnera, L; Travaglini, S; Ottone, T; Divona, M; De , E; Bellis, ; Savi, A; Banella, C; Noguera, Ni; Di , D; Fusco, ; Monteleone, I; Voso, Mt Articolo su rivista
17-mag-2023 Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P Articolo su rivista
Mostrati risultati da 41 a 60 di 63
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile